Sort
10,766 grants matching “checkpoint inhibitor”
Understanding and improving novel oncolytic viruses for pancreatic cancer
$448,536Valery Zurabovich Grdzelishvili · University Of North Carolina Charlotte · R15 · FY2024 · CA
Novel mechanisms regulating PD-1 signaling and function
$448,417Adam Mor · Columbia University Health Sciences · R01 · FY2023 · AI
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$448,416Cristian T Badea · Duke University · U24 · FY2020 · CA
Epigenetic Therapy for Thoracic Malignanceis
$448,245David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$448,200Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2020 · CA
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$447,953A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
TIGIT in acute kidney injury and repair
$447,939Sanjeev Noel · Johns Hopkins University · R01 · FY2025 · DK
From the Past to the Future: Chimeric Antigen Receptor T cells for Lymphoid Malignancies
$447,870Joseph Anthony Fraietta · University Of Pennsylvania · P01 · FY2024 · CA
Project 3: Hedgehog Inhibition to Enhance Response to ICI Therapy
$447,715Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting
$447,565Sebastian Joyce · Vanderbilt University Medical Center · R01 · FY2022 · DE
Project 2: Combined CAR-T cell therapy
$447,559Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Tumor cell -TAM Paracrine Signaling in Breast Cancer
$447,481Elizabeth S. Yeh · Indiana University Indianapolis · R01 · FY2025 · CA
Interplay between tumor and microenvironment in bone metastasis
$447,407Paul B Fisher · Virginia Commonwealth University · R01 · FY2024 · CA
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance
$447,367Aimee L Edinger · University Of California-Irvine · R01 · FY2023 · CA
Expanding the tumor antigen landscape and maintaining APCs in a T cell-activating state to restore tumor immunity
$447,162Eduardo Davila · University Of Colorado Denver · R01 · FY2023 · CA
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers
$447,102Richard A. Cerione · Cornell University · R01 · FY2022 · CA
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers
$447,102Richard A. Cerione · Cornell University · R01 · FY2023 · CA
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$446,886E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2019 · NS
Regulation of Chromosome Segregation in Human Cells
$446,825Prasad V Jallepalli · Sloan-Kettering Inst Can Research · R01 · FY2017 · GM
Regulation of Chromosome Segregation in Human Cells
$446,825Prasad V Jallepalli · Sloan-Kettering Inst Can Research · R01 · FY2014 · GM
Regulation of Chromosome Segregation in Human Cells
$446,825Prasad V Jallepalli · Sloan-Kettering Inst Can Research · R01 · FY2016 · GM
Regulation of Chromosome Segregation in Human Cells
$446,825Prasad V Jallepalli · Sloan-Kettering Inst Can Research · R01 · FY2015 · GM
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$446,690Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DE
Project 1: Decoding, Modeling and Targeting Oncohistones and an Oncohistone-like Protein
$446,630Nada Jabado · Rockefeller University · P01 · FY2022 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$446,627Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA